Skip to main content
Pulmonary Therapy logoLink to Pulmonary Therapy
. 2025 May 9;11(2):305. doi: 10.1007/s41030-025-00298-y

Correction: A Phase 2a, Randomized, Placebo-Controlled Human Challenge Trial to Evaluate the Efficacy and Safety of Molnupiravir in Healthy Participants Inoculated with Respiratory Syncytial Virus

Mickie H Cheng 1,, Alex J Mann 2, Brian M Maas 1, Tian Zhao 1, Melissa Bevan 2, Andrea K Schaeffer 1, Laura E Liao 1, Andrew P Catchpole 2, David W Hilbert 1, S Aubrey Stoch 1, Carisa S De Anda 1
PMCID: PMC12102405  PMID: 40346422

Correction: Pulm Ther 10.1007/s41030-025-00289-z

The Clinical Trial Registration Number has been corrected from 'NCT0555005' to 'NCT05559905'. The original article has been corrected.


Articles from Pulmonary Therapy are provided here courtesy of Springer

RESOURCES